Glutathione S-transferase π: a potential role in antitumor therapy

References

• TownsendDMTewKDTapieroHThe importance of glutathione in human diseaseBiomed Pharmacother2003573–414515512818476
   PubMed Web of Science ®Google Scholar
• TewKDTownsendDMRegulatory functions of glutathione S-transferase P1-1 unrelated to detoxificationDrug Metab Rev201143217919321351850
   PubMed Web of Science ®Google Scholar
• SawersLFergusonMJIhrigBRGlutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell linesBr J Cancer201411161150115825010864
   PubMed Web of Science ®Google Scholar
• SatoKTsuchidaSTamaiKAnti-cancer drug resistance and glutathione S-transferasesGan To Kagaku Ryoho1989163 Pt 25925982650631
   PubMedGoogle Scholar
• IjSChengALTsaiTFLayJDRetinoic acid-induced apoptosis and regression of a refractory Epstein-Barr virus-containing T cell lymphoma expressing multidrug-resistance phenotypesBr J Haematol19938548268287918055
   PubMed Web of Science ®Google Scholar
• QinFQinXZhangXJiaHWExpression and significance of P-glycoprotein, glutathione S-transferase-pi and Topoisomerase II in gastric carcinomasAi Zheng200221216717012479068
   PubMedGoogle Scholar
• ZhuXHLiJYXiaXMMultidrug resistance mechanisms in cell line HL-60/VCRAi Zheng200221121310131312520737
   PubMedGoogle Scholar
• TownsendDMFindlayVLTewKDGlutathione S-transferases as regulators of kinase pathways and anticancer drug targetsMethods Enzymol200540128730716399394
   PubMed Web of Science ®Google Scholar
• SchecterRLAlaoui-JamaliMABatistGGlutathione S-transferase in chemotherapy resistance and in carcinogenesisBiochem Cell Biol19927053493531353967
   PubMed Web of Science ®Google Scholar
• WuBDongDHuman cytosolic glutathione transferases: structure, function, and drug discoveryTrends Pharmacol Sci2012331265666823121834
   PubMed Web of Science ®Google Scholar
• MorelFRauchCPetitEGene and Protein Characterization of the Human Glutathione S-Transferase Kappa and Evidence for a Peroxisomal LocalizationJ Biol Chem200427916162461625314742434
   PubMed Web of Science ®Google Scholar
• DengQHeBPanYPolymorphisms of GSTA1 contribute to elevated cancer risk: evidence from 15 studiesJ BUON201520128729525778330
   PubMed Web of Science ®Google Scholar
• RussoASaideASmaldoneSFaraonioRRussoGRole of uL3 in Multidrug Resistance in p53-Mutated Lung Cancer CellsInt J Mol Sci2017183547
   PubMed Web of Science ®Google Scholar
• DepeillePCuqPMarySGlutathione S-transferase M1 and multidrug resistance protein 1 act in synergy to protect melanoma cells from vincristine effectsMol Pharmacol200465489790515044619
   PubMed Web of Science ®Google Scholar
• ChenWYMaoWMZhaoLExpression of P-gp, GST-pi and Topo II alpha in gastric and colorectal cancers and their clinical significanceZhonghua Zhong Liu Za Zhi2005271273874016483485
   PubMedGoogle Scholar
• AsojoOAHommaKSedlacekMX-ray structures of Na-GST-1 and Na-GST-2 two glutathione S-transferase from the human hookworm Necator americanusBMC Struct Biol2007714217594497
   PubMed Web of Science ®Google Scholar
• KelleherAZhanBAsojoOAStructure of monomeric Na-GST-3, a glutathione S-transferase from the major human hookworm parasite Necator americanusActa Crystallogr Sect F Struct Biol Cryst Commun2013698839843
   PubMedGoogle Scholar
• TownsendDMTewKDThe role of glutathione-S-transferase in anticancer drug resistanceOncogene200322477369737514576844
   PubMed Web of Science ®Google Scholar
• VasievaOThe many faces of glutathione transferase piCurr Mol Med201111212913921342130
   PubMed Web of Science ®Google Scholar
• LiGDaiJWangYOverexpression and its clinical significance of multi-drug resistance associated genes in lung cancer tissuesZhongguo Fei Ai Za Zhi200251353721315026
   PubMedGoogle Scholar
• HsuC-HChenC-LHongR-LChenK-LLinJ-FChengA-LPrognostic Value of Multidrug Resistance 1, Glutathione-S-Transferase-π and p53 in Advanced Nasopharyngeal Carcinoma Treated with Systemic ChemotherapyOncology200262430531212138237
   PubMed Web of Science ®Google Scholar
• CollierJDBennettMKHallACattanARLendrumRBassendineMFExpression of glutathione S-transferases in normal and malignant pancreas: an immunohistochemical studyGut19943522662698307481
   PubMed Web of Science ®Google Scholar
• SuFHuXJiaWGongCSongEHamarPGlutathion s transferase π indicates chemotherapy resistance in breast cancerJ Surg Res2003113110210812943817
   PubMed Web of Science ®Google Scholar
• EzzikouriSBenjellounSPineauPHuman genetic variation and the risk of hepatocellular carcinoma developmentHepatol Int20137382083126201919
   PubMed Web of Science ®Google Scholar
• Bennaceur-GriscelliABosqJKoscielnySHigh Level of Glutathione-S-Transferase Expression in Mantle Cell LymphomasClin Cancer Res20041093029303415131039
   PubMed Web of Science ®Google Scholar
• DepeillePCuqPPassagneIEvrardAVianLCombined effects of GSTP1 and MRP1 in melanoma drug resistanceBr J Cancer200593221622315999103
   PubMed Web of Science ®Google Scholar
• LushchakVIGlutathione homeostasis and functions: potential targets for medical interventionsJ Amino Acids20122012573683722500213
   PubMedGoogle Scholar
• ZwYZhangJTownsendDMTewKDOxidative stress, redox regulation and diseases of cellular differentiationBiochim Biophys Acta18502015816071621
   Google Scholar
• ChenWSeefeldtTYoungAMicrotubule S-glutathionylation as a potential approach for antimitotic agentsBMC Cancer201212124522703118
   PubMed Web of Science ®Google Scholar
• TewKDManevichYGrekCXiongYUysJTownsendDMThe role of glutathione S-transferase P in signaling pathways and S-glutathionylation in cancerFree Radic Biol Med2011512z299313
   PubMed Web of Science ®Google Scholar
• SeefeldtTZhaoYChenWCharacterization of a novel dithiocarbamate glutathione reductase inhibitor and its use as a tool to modulate intracellular glutathioneJ Biol Chem200928452729273719049979
   PubMed Web of Science ®Google Scholar
• LeeH-CKimD-WJungK-YIncreased expression of antioxidant enzymes in radioresistant variant from U251 human glioblastoma cell lineInt J Mol Med200413688388715138630
   PubMed Web of Science ®Google Scholar
• GateLMajumdarRSLunkATewKDIncreased Myeloproliferation in Glutathione S-Transferase π-deficient Mice Is Associated with a Deregulation of JNK and Janus Kinase/STAT PathwaysJ Biol Chem2004279108608861614684749
   PubMed Web of Science ®Google Scholar
• SauAFilomeniGPezzolaSTargeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell linesMol Biosyst201284994100622068640
   PubMedGoogle Scholar
• ZhangLBlackwellKAltaevaAShiZHabelhahHTRAF2 phosphorylation promotes NF-κB–dependent gene expression and inhibits oxidative stress-induced cell deathMol Biol Cell201122112814021119000
   PubMed Web of Science ®Google Scholar
• ChenDLiuJRuiBGSTpi protects against angiotensin II-induced proliferation and migration of vascular smooth muscle cells by preventing signal transducer and activator of transcription 3 activationBiochim Biophys Acta20141843245446324321768
   PubMed Web of Science ®Google Scholar
• SauAPellizzari TregnoFValentinoFFedericiGCaccuriAMGlutathione transferases and development of new principles to overcome drug resistanceArch Biochem Biophys2010500211612220494652
   PubMed Web of Science ®Google Scholar
• de LucaAMeiGRosatoNThe fine-tuning of TRAF2–GSTP1-1 interaction: effect of ligand binding and in situ detection of the complexCell Death Dis201451e101524457959
   PubMed Web of Science ®Google Scholar
• CoattiGCMarcariniJCSartoriDFidelisQCFerreiraDTMantovaniMSCytotoxicity, genotoxicity and mechanism of action (via gene expression analysis) of the indole alkaloid aspidospermine (antiparasitic) extracted from Aspidosperma polyneuron in HepG2 cellsCytotechnology20166841161117025894792
   PubMed Web of Science ®Google Scholar
• PalumboCde LucaARosatoNForgioneMRotiliDCaccuriAMc-Jun N-terminal kinase activation by nitrobenzoxadiazoles leads to late-stage autophagy inhibitionJ Transl Med20161413726847645
   PubMed Web of Science ®Google Scholar
• FulciCRotiliDde LucaAA new nitrobenzoxadiazole-based GSTP1-1 inhibitor with a previously unheard of mechanism of action and high stabilityJ Enzyme Inhib Med Chem201732124024728097896
   PubMed Web of Science ®Google Scholar
• Pellizzari TregnoFSauAPezzolaSIn vitro and in vivo efficacy of 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) on human melanomaEur J Cancer200945142606261719665369
   PubMed Web of Science ®Google Scholar
• HwLAli-OsmanFGenetic polymorphism and function of glutathione S-transferases in tumor drug resistanceCurr Opin Pharmacol20077436737417681492
   PubMed Web of Science ®Google Scholar
• BartoliniDGalliFThe functional interactome of GSTP: A regulatory biomolecular network at the interface with the Nrf2 adaption response to oxidative stressJ Chromatogr B Analyt Technol Biomed Life Sci201610192944
   PubMed Web of Science ®Google Scholar
• KouXChenNFengZLuoLANYinZGSTP1 negatively regulates Stat3 activation in epidermal growth factor signalingOncol Lett2013531053105723426146
   PubMed Web of Science ®Google Scholar
• LiFFernandezPPRajendranPHuiKMSethiGDiosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cellsCancer Lett2010292219720720053498
   PubMed Web of Science ®Google Scholar
• TownsendDMShenHStarosALGateLTewKDEfficacy of a glutathione S-transferase pi-activated prodrug in platinum-resistant ovarian cancer cellsMol Cancer Ther20021121089109512481432
   PubMed Web of Science ®Google Scholar
• di PietroGMagnoLAVRios-SantosFGlutathione S-transferases: an overview in cancer researchExpert Opin Drug Metab Toxicol20106215317020078251
   PubMed Web of Science ®Google Scholar
• HarrisMJCogganMLangtonLWilsonSRBoardPGPolymorphism of the Pi class glutathione S-transferase in normal populations and cancer patientsPharmacogenetics19988127319511178
   PubMedGoogle Scholar
• CadoniGBocciaSPetrelliLA review of genetic epidemiology of head and neck cancer related to polymorphisms in metabolic genes, cell cycle control and alcohol metabolismActa Otorhinolaryngol Ital201232111122500060
   PubMed Web of Science ®Google Scholar
• HuangWWangWZhouMChenSZhangXAssociation of glutathione S-transferase polymorphisms (GSTM1 and GSTT1) with primary open-angle glaucoma: An evidence-based meta-analysisGene20135262808623747403
   PubMed Web of Science ®Google Scholar
• HabdousMSiestGHerbethBVincent-ViryMVisvikisSGlutathione S-transferases genetic polymorphisms and human diseases: overview of epidemiological studiesAnn Biol Clin20046211524
   PubMed Web of Science ®Google Scholar
• DouradoDFFernandesPARamosMJMannervikBMechanism of glutathione transferase P1-1-catalyzed activation of the prodrug canfosfamide (TLK286, TELCYTA)Biochemistry201352458069807824066958
   PubMed Web of Science ®Google Scholar
• NasrASamiRIbrahimNDarwishDGlutathione S transferase (GSTP 1, GSTM 1, and GSTT 1) gene polymorphisms in Egyptian patients with acute myeloid leukemiaIndian J Cancer201552449049526960454
   PubMed Web of Science ®Google Scholar
• SunNSunXChenBMRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancerCancer Chemother Pharmacol201065343744619568750
   PubMed Web of Science ®Google Scholar
• KhruninAVMoisseevAGorbunovaVLimborskaSGenetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patientsPharmacogenomics J2010101546119786980
   PubMed Web of Science ®Google Scholar
• BurgDFilippovDVHermannsRvan der MarelGAvan BoomJHMulderGJPeptidomimetic Glutathione Analogs as Novel γGT Stable GST InhibitorsBioorg Med Chem200210119520511738622
   PubMed Web of Science ®Google Scholar
• LiTLiuGLiHYangXJingYZhaoGThe synthesis of ethacrynic acid thiazole derivatives as glutathione S-transferase pi inhibitorsBioorg Med Chem20122072316232222370342
   PubMed Web of Science ®Google Scholar
• EnoiuMAberkaneHSalazarJFEvidence for the pro-oxidant effect of gamma-glutamyltranspeptidase-related enzymeFree Radic Biol Med200029982583311063908
   PubMed Web of Science ®Google Scholar
• NakajimaTReversal of Multiple Drug Resistance in Cholangiocarcinoma by the Glutathione S-Transferase-pi-Specific Inhibitor O1-Hexadecyl-gamma-glutamyl-S-benzylcysteinyl-D-phenylglycine EthylesterJ Pharmacol Exp Ther2003306386186912805482
   PubMed Web of Science ®Google Scholar
• RazaAGalliNCallanderNPhase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra(R), TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndromeJ Hematol Oncol2009212019439093
   PubMed Web of Science ®Google Scholar
• RazaAGaliliNSmithSPhase 1 multicenter dose-escalation study of ezatiostat hydrochloride (TLK199 tablets), a novel glutathione analog prodrug, in patients with myelodysplastic syndromeBlood2009113266533654019398716
   PubMed Web of Science ®Google Scholar
• RazaAGaliliNMulfordDPhase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS)J Hematol Oncol2012511822546242
   PubMed Web of Science ®Google Scholar
• MahadevanDSuttonGREzatiostat hydrochloride for the treatment of myelodysplastic syndromesExpert Opin Investig Drugs2015245725733
   PubMed Web of Science ®Google Scholar
• RicciGde MariaFAntoniniG7-Nitro-2,1,3-benzoxadiazole derivatives, a new class of suicide inhibitors for glutathione S-transferases. Mechanism of action of potential anticancer drugsJ Biol Chem200528028263972640515888444
   PubMed Web of Science ®Google Scholar
• PaselloMMichelacciFSciontiIOvercoming glutathione S-transferase P1-related cisplatin resistance in osteosarcomaCancer Res200868166661666818701490
   PubMed Web of Science ®Google Scholar
• AscioneACianfrigliaMDupuisMLThe glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol overcomes the MDR1-P-glycoprotein and MRP1-mediated multi-drug resistance in acute myeloid leukemia cellsCancer Chemother Pharmacol200964241942419288261
   PubMed Web of Science ®Google Scholar
• ScotlandiKRemondiniDCastellaniGOvercoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcomeJ Clin Oncol200927132209221619307502
   PubMed Web of Science ®Google Scholar
• de LucaAPellizzari TregnoFSauAGlutathione S-transferase P1-1 as a target for mesothelioma treatmentCancer Sci2013104222323023121163
   PubMed Web of Science ®Google Scholar
• FilomeniGTurellaPDupuisML6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol, a specific glutathione S-transferase inhibitor, overcomes the multidrug resistance (MDR)-associated protein 1-mediated MDR in small cell lung cancerMol Cancer Ther20087237137918281520
   PubMed Web of Science ®Google Scholar
• TentoriLDorioASMazzonEThe glutathione transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) increases temozolomide efficacy against malignant melanomaEur J Cancer20114781219123021269821
   PubMed Web of Science ®Google Scholar
• de LucaAFedericiLde CanioMStellaLCaccuriAMNew Insights into the Mechanism of JNK1 Inhibition by Glutathione Transferase P1-1Biochemistry201251377304731222920299
   PubMed Web of Science ®Google Scholar
• AwasthiYCSharmaRSinghalSSHuman glutathione S-transferasesInt J Biochem19942632953088187927
   PubMedGoogle Scholar
• RotiliDde LucaATarantinoDSynthesis and structure–activity relationship of new cytotoxic agents targeting human glutathione-S-transferasesEur J Med Chem20158915617125462236
   PubMed Web of Science ®Google Scholar
• de LucaARotiliDCarpaneseDA novel orally active water-soluble Inhibitor of human glutathione transferase exerts a potent and selective antitumor activity against human melanoma xenograftsOncotarget2015664126414325595904
   PubMedGoogle Scholar
• BregniGGalliGGevorgyanAde BraudFdi CosimoSTras-tuzumab cardiac toxicity: a problem we put our heart intoTumori2016102115
   PubMed Web of Science ®Google Scholar
• YangA-JLiC-CLuC-YActivation of the cAMP/CREB/Inducible cAMP Early Repressor Pathway Suppresses Andrographolide-Induced Gene Expression of the π Class of Glutathione S-Transferase in Rat Primary HepatocytesJ Agric Food Chem20105831993200020063885
   PubMed Web of Science ®Google Scholar
• LinC-YFuR-HChouR-HInhibition of JNK by pi class of glutathione S-transferase through PKA/CREB pathway is associated with carnosic acid protection against 6-hydroxydopamine-induced apoptosisFood Chem Toxicol201710319420228288932
   PubMed Web of Science ®Google Scholar
• SatyamAHockerMDKane-MaguireKAMorganASVillarHOLyttleMHDesign, Synthesis, and Evaluation of Latent Alkylating Agents Activated by Glutathione S-TransferaseJ Med Chem1996398173617478648613
   PubMed Web of Science ®Google Scholar
• TewKDTLK-286: a novel glutathione S-transferase-activated prodrugExpert Opin Investig Drugs200514810471054
   PubMed Web of Science ®Google Scholar
• RamsayEEDildaPJGlutathione S-conjugates as prodrugs to target drug-resistant tumorsFront Pharmacol2014511818125157234
   PubMed Web of Science ®Google Scholar
• MorganASSandersonPEBorchRFTumor efficacy and bone marrow-sparing properties of TER286, a cytotoxin activated by glutathione S-transferaseCancer Res19985812256825759635580
   PubMed Web of Science ®Google Scholar
• RosenLSBrownJLaxaBPhase I study of TLK286 (glutathione S-transferase P1-1 activated glutathione analog) in advanced refractory solid malignanciesClin Cancer Res2003951628163812738715
   PubMed Web of Science ®Google Scholar
• RosenLSLaxaBBoulosLPhase 1 study of TLK286 (Telcyta) administered weekly in advanced malignanciesClin Cancer Res200410113689369815173075
   PubMed Web of Science ®Google Scholar
• KavanaghJJGershensonDMChoiHMulti-institutional phase 2 study of TLK286 (TELCYTAtm, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancerInt J Gynecol Cancer200515459360016014111
   PubMed Web of Science ®Google Scholar
• EdelmanMJNovel cytotoxic agents for non-small cell lung cancerJ Thorac Oncol20061775275517409954
   PubMed Web of Science ®Google Scholar
• RaezLELilenbaumRNew developments in chemotherapy for advanced non-small cell lung cancerCurr Opin Oncol200618215616116462185
   PubMed Web of Science ®Google Scholar
• KavanaghJJLevenbackCFRamirezPTPhase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancerJ Hematol Oncol201031920222977
   PubMed Web of Science ®Google Scholar
• SequistLVFidiasPMTemelJSPhase 1-2a multicenter dose-ranging study of canfosfamide in combination with carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cell lung cancerJ Thorac Oncol20094111389139619701107
   PubMed Web of Science ®Google Scholar
• BogdanCNitric oxide synthase in innate and adaptive immunity: an updateTrends Immunol201536316117825687683
   PubMed Web of Science ®Google Scholar
• SinghSGuptaAKNitric oxide: role in tumour biology and iNOS/NO-based anticancer therapiesCancer Chemother Pharmacol20116761211122421544630
   PubMed Web of Science ®Google Scholar
• ShamiPJSaavedraJEWangLYJS-K, a glutathione/glutathione S-transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activityMol Cancer Ther20032440941712700285
   PubMed Web of Science ®Google Scholar
• BurkeAJSullivanFJGilesFJGlynnSAThe yin and yang of nitric oxide in cancer progressionCarcinogenesis201334350351223354310
   PubMed Web of Science ®Google Scholar
• KeeferLBroad-Spectrum Anti-Cancer Activity of O2-Arylated DiazeniumdiolatesFor Immunopathol Dis Therap201013205218
   PubMedGoogle Scholar
• KiziltepeTHideshimaTIshitsukaKJS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cellsBlood2007110270971817384201
   PubMed Web of Science ®Google Scholar
• KiziltepeTAndersonKCKutokJLJS-K has potent anti- angiogenic activity in vitro and inhibits tumour angiogenesis in a multiple myeloma model in vivoJ Pharm Pharmacol201062114515120723011
   PubMed Web of Science ®Google Scholar
• MaciagAEChakrapaniHSaavedraJEThe nitric oxide prodrug JS-K is effective against non-small-cell lung cancer cells in vitro and in vivo: involvement of reactive oxygen speciesJ Pharmacol Exp Ther2011336231332020962031
   PubMed Web of Science ®Google Scholar
• ShamiPJMaciagAEEddingtonJKJS-K, an arylating nitric oxide (NO) donor, has synergistic anti-leukemic activity with cytara-bine (ARA-C)Leuk Res200933111525152919193435
   PubMed Web of Science ®Google Scholar
• XueRWuJLuoXDesign, Synthesis, and Evaluation of Diazeniumdiolate-Based DNA Cross-Linking Agents Activatable by Glutathione S-TransferaseOrg Lett2016182051965199
   PubMed Web of Science ®Google Scholar
• KaczmarekMZHollandRJLavanierSAMechanism of action for the cytotoxic effects of the nitric oxide prodrug JS-K in murine erythroleukemia cellsLeuk Res201438337738224461365
   PubMed Web of Science ®Google Scholar
• RenZKarSWangZWangMSaavedraJECarrBIJS-K, a novel non-ionic diazeniumdiolate derivative, inhibits Hep 3B hepatoma cell growth and induces c-Jun phosphorylation via multiple MAP kinase pathwaysJ Cell Physiol2003197342643414566972
   PubMed Web of Science ®Google Scholar
• McmurtryVSaavedraJENieves-AliceaRSimeoneAMKeeferLKTariAMJS-K, a nitric oxide-releasing prodrug, induces breast cancer cell death while sparing normal mammary epithelial cellsInt J Oncol201138496397121271218
   PubMed Web of Science ®Google Scholar
• KaurITerrazasMKosakKMKernSEBoucherKMShamiPJCellular distribution studies of the nitric oxide-generating antineoplas-tic prodrug O(2)-(2,4-dinitrophenyl)1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate formulated in Pluronic P123 micellesJ Pharm Pharmacol20136591329133623927471
   PubMed Web of Science ®Google Scholar
• SimeoneAMMcMurtryVNieves-AliceaRTIMP-2 mediates the anti-invasive effects of the nitric oxide-releasing prodrug JS-K in breast cancer cellsBreast Cancer Res2008103R4418474097
   PubMed Web of Science ®Google Scholar
• KitagakiJYangYSaavedraJEColburnNHKeeferLKPerantoniAONitric oxide prodrug JS-K inhibits ubiquitin E1 and kills tumor cells retaining wild-type p53Oncogene200928461962418978812
   PubMed Web of Science ®Google Scholar
• WeyerbrockAOsterbergNPsarrasNJS-K, a glutathione S-transferase-activated nitric oxide donor with antineoplastic activity in malignant gliomasNeurosurgery2012702497510 discussion 51021849924
   PubMed Web of Science ®Google Scholar
• LaschakMSpindlerKDSchraderAJJS-K, a glutathione/glutathione S-transferase-activated nitric oxide releasing prodrug inhibits androgen receptor and WNT-signaling in prostate cancer cellsBMC Cancer20121213022462810
   PubMed Web of Science ®Google Scholar
• ChakrapaniHKalathurRCMaciagAESynthesis, mechanistic studies, and anti-proliferative activity of glutathione/glutathione S-transferase-activated nitric oxide prodrugsBioorg Med Chem200816229764977118930407
   PubMed Web of Science ®Google Scholar
• QiuMChenLTanGA reactive oxygen species activation mechanism contributes to JS-K-induced apoptosis in human bladder cancer cellsSci Rep201551510426458509
   PubMed Web of Science ®Google Scholar
• EdesKCassidyPShamiPJMoosPJJS-K, a nitric oxide prodrug, has enhanced cytotoxicity in colon cancer cells with knockdown of thioredoxin reductase 1PLoS One201051e878620098717
   PubMed Web of Science ®Google Scholar
• LiuLWangDWangJWangSThe Nitric Oxide Prodrug JS-K Induces Ca(2+)-Mediated Apoptosis in Human Hepatocellular Carcinoma HepG2 CellsJ Biochem Mol Toxicol201630419219926616367
   PubMed Web of Science ®Google Scholar
• LiuJLiCQuWNitric oxide prodrugs and metallochemo-therapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulationMol Cancer Ther20043670971415210857
   PubMed Web of Science ®Google Scholar
• KaurIKosakKMTerrazasMEffect of a Pluronic® P123 formulation on the nitric oxide-generating drug JS-KPharm Res20153241395140625330743
   PubMed Web of Science ®Google Scholar
• KuhlmannMKBurkhardtGKöhlerHInsights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical applicationNephrol Dial Transplant19971212247824809430835
   PubMed Web of Science ®Google Scholar
• HospersGAEisenhauerEAde VriesEGThe sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospectsBr J Cancer1999805–662963810360638
   PubMed Web of Science ®Google Scholar
• IorioASpinelliMPolimantiRGSTA1 gene variation associated with gestational hypertension and its involvement in pregnancy-related pathogenic conditionsEur J Obstet Gynecol Reprod Biol2015194343726321410
   PubMed Web of Science ®Google Scholar
• BonifaziFStorciGBandiniGGlutathione transferase-A2 S112T polymorphism predicts survival, transplant-related mortality, busulfan and bilirubin blood levels after allogeneic stem cell transplantationHaematologica201499117217924056816
   PubMed Web of Science ®Google Scholar
• ZhangWModenOMannervikBDifferences among allelic variants of human glutathione transferase A2-2 in the activation of azathioprineChem Biol Interact2010186211011720434437
   PubMed Web of Science ®Google Scholar
• RodriguesDAMartinsJVSilvaKSEGSTM1 polymorphism in patients with clinical manifestations of atherosclerosisGenetics and Molecular Research: GMR2017161
   Web of Science ®Google Scholar
• Abdur RehmanMYKamalATaqiMMMalikRNTracing biomarker of PAH-exposure and susceptibility factor (GSTM-polymorphism) among cancer patients in PakistanChemosphere201717838439028340461
   PubMed Web of Science ®Google Scholar
• TanwarRIyengarARNageshKSPatilSSubhashBVGSTM1 null polymorphism prevalence in tobacco users, oral leukoplakia and oral squamous cell carcinoma patients in South Indian population: A polymerase chain reaction studyIndian J Dent Res201627435335827723629
   PubMedGoogle Scholar
• XuYWangJDongWGSTM3 A/B polymorphism and risk for head and neck cancer: a meta-analysisPLoS One201491e8385124416175
   PubMed Web of Science ®Google Scholar
• FengXDongCQShiJJZhouHFHeWZhengBSLack of association of glutathione S-transferase M3 gene polymorphism with the susceptibility of lung cancerAsian Pac J Cancer Prev20121394465446823167362
   PubMedGoogle Scholar
• BhatAMasoodAWaniKAPromoter methylation and gene polymorphism are two independent events in regulation of GSTP1 gene expressionTumour Biol2017394101042831769756328443466
   PubMedGoogle Scholar
• HuangXKHuangYHHuangJHLiangJYGlutathione S-transferase P1 Ile105Val Polymorphism and Male Infertility Risk: An Updated Meta-analysisChin Med J (Engl)2017130897998528397729
   PubMed Web of Science ®Google Scholar
• SoaresPOMaluf CuryPMendoza LopezRVGTSP1 expression in non-smoker and non-drinker patients with squamous cell carcinoma of the head and neckPLoS One2017128e018260028817620
   PubMed Web of Science ®Google Scholar
• BasharatZYasminAEnergy landscape of a GSTP1 polymorph linked with cytological function decay in response to chemical stressorsGene2017609192728153749
   PubMed Web of Science ®Google Scholar
• ChoiBKimMGHanNPopulation pharmacokinetics and pharmacodynamics of busulfan with GSTA1 polymorphisms in patients undergoing allogeneic hematopoietic stem cell transplantationPharmacogenomics201516141585159426419450
   PubMed Web of Science ®Google Scholar
• SongYShanZLuoCGlutathione S-Transferase T1 (GSTT1) Null Polymorphism, Smoking, and Their Interaction in Coronary Heart Disease: A Comprehensive Meta-AnalysisHeart Lung Circ201726436237027686690
   PubMed Web of Science ®Google Scholar
• JangSGKimIJKangHCGSTT2 promoter polymorphisms and colorectal cancer riskBMC Cancer200771617250773
   PubMed Web of Science ®Google Scholar
• ChelvanayagamGWilceMCParkerMWTanKLBoardPGHomology model for the human GSTT2 Theta class glutathione transferaseProteins19972711181309037717
   PubMed Web of Science ®Google Scholar
• XuYTWangJYinRGenetic polymorphisms in Glutathione S-transferase Omega (GSTO) and cancer risk: a meta-analysis of 20 studiesSci Rep20144657825300926
   PubMed Web of Science ®Google Scholar
• PolimantiRGrazianoMELazzarinNVaqueroEManfellottoDFuciarelliMGSTO1 uncommon genetic variants are associated with recurrent miscarriage riskFertil Steril2014101373573924417908
   PubMed Web of Science ®Google Scholar
• WangZQuKHuangZGlutathione S-transferase O2 gene rs157077 polymorphism predicts response to transarterial chemoembolization in hepatocellular carcinomaTumour Biol20153686463646925835968
   PubMedGoogle Scholar
• StamenkovicMRadicTStefanovicIGlutathione S-transferase omega-2 polymorphism Asn142Asp modifies the risk of age-related cataract in smokers and subjects exposed to ultraviolet irradiationClin Exp Ophthalmol201442327728323927022
   PubMed Web of Science ®Google Scholar
• LangaeeTYZhongGLiWThe influence of human GSTZ1 gene haplotype variations on GSTZ1 expressionPharmacogenet Genomics201525523924525738370
   PubMed Web of Science ®Google Scholar
• ShroadsALCoatsBSMcDonoughCWLangaeeTStacpoolePWHaplotype variations in glutathione transferase zeta 1 influence the kinetics and dynamics of chronic dichloroacetate in childrenJ Clin Pharmacol2015551505525079374
   PubMed Web of Science ®Google Scholar
• Karakas-CelikSArasNAtesCGlutathione S-transferase Z1 (GSTZ1) gene polymorphism in gastric cancer: a preliminary study in a Turkish populationLab Med2014451374224719983
   PubMed Web of Science ®Google Scholar
• BurgDFilippovDVHermannsRvan der MarelGAvan BoomJHMulderGJPeptidomimetic glutathione analogs as novel gammaGT stable GST inhibitorsBioorg Med Chem200210119520511738622
   PubMed Web of Science ®Google Scholar
• LiTLiuGLiHYangXJingYZhaoGThe synthesis of ethacrynic acid thiazole derivatives as glutathione S-transferase pi inhibitorsBioorg Med Chem20122072316232222370342
   PubMed Web of Science ®Google Scholar
• MahadevanDSuttonGREzatiostat hydrochloride for the treatment of myelodysplastic syndromesExpert Opin Investig Drugs2015245725733
   PubMed Web of Science ®Google Scholar
• FulciCRotiliDDe LucaAA new nitrobenzoxadiazole-based GSTP1-1 inhibitor with a previously unheard of mechanism of action and high stabilityJ Enzyme Inhib Med Chem201732124024728097896
   PubMed Web of Science ®Google Scholar
• RotiliDDe LucaATarantinoDSynthesis and structure – activity relationship of new cytotoxic agents targeting human glutathione-S-transferasesEur J Med Chem20158915617125462236
   PubMed Web of Science ®Google Scholar
• De LucaAMeiGRosatoNThe fine-tuning of TRAF2-GSTP1-1 interaction: effect of ligand binding and in situ detection of the complexCell Death Dis20145e101524457959
   PubMed Web of Science ®Google Scholar
• GrazianiGArtusoSDe LucaAA new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenibBiochem Pharmacol2015951162725795251
   PubMed Web of Science ®Google Scholar
• RamsayEEDildaPJGlutathione S-conjugates as prodrugs to target drug-resistant tumorsFront Pharmacol2014518125157234
   PubMed Web of Science ®Google Scholar
• TewKDTLK-286: a novel glutathione S-transferase-activated prod-rugExpert Opin Investig Drugs200514810471054
   PubMed Web of Science ®Google Scholar
• VergoteIFinklerNdel CampoJPhase 3 randomised study of canfosfamide (Telcyta, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancerEur J Cancer200945132324233219515553
   PubMed Web of Science ®Google Scholar
• QiuMKeLZhangSZengXFangZLiuJJS-K, a GST-activated nitric oxide donor prodrug, enhances chemo-sensitivity in renal carcinoma cells and prevents cardiac myocytes toxicity induced by DoxorubicinCancer Chemother Pharmacol201780227528628608259
   PubMed Web of Science ®Google Scholar